Copyright
©The Author(s) 2024.
World J Cardiol. May 26, 2024; 16(5): 231-239
Published online May 26, 2024. doi: 10.4330/wjc.v16.i5.231
Published online May 26, 2024. doi: 10.4330/wjc.v16.i5.231
Figure 1 Proposed work flow to evaluate the ischemic stroke and intracranial bleeding risks in patients with concurrent cerebral amyloid angiopathy and atrial fibrillation.
CAA: Cerebral amyloid angiopathy; MRI: Magnetic resonance imaging; AF: Atrial fibrillation.
- Citation: Fusco L, Palamà Z, Scarà A, Borrelli A, Robles AG, De Masi De Luca G, Romano S, Sciarra L. Management of cerebral amyloid angiopathy and atrial fibrillation: We are still far from precision medicine. World J Cardiol 2024; 16(5): 231-239
- URL: https://www.wjgnet.com/1949-8462/full/v16/i5/231.htm
- DOI: https://dx.doi.org/10.4330/wjc.v16.i5.231